Objectives and Expected Outcomes: The objective of this program, titled "2026 Discovery of Novel Therapeutic Target for Pediatric Brain Tumor," is to contribute to advancing cancer therapeutics by exploring innovative targets specific to pediatric brain tumors. The program provides hands-on training and research experience, immersing interns in the intricacies of translational oncology and therapeutic discovery. By fostering skills in research methodology and experimental design, this program aims to enhance interns' technical capabilities and understanding of the molecular underpinnings of cancer, with an emphasis on identifying new, effective therapeutic strategies for pediatric populations. Expected outcomes include the interns’ improved proficiency in cancer biology, expertise in lab-based research, and potentially the identification of novel targets for further therapeutic exploration. Primary Target Countries for Student Acquisition: The program will target students from countries including Vietnam and Malaysia. Senior undergraduate students and second-year master's students are welcome to apply. This selection aims to create a diverse cohort, enhancing cross-cultural research collaboration and facilitating broader global exchange in pediatric oncology. Students who have molecular and cellular biology skills will be given priority consideration. Collaborators: This project will be conducted in partnership with Taipei Medical University Hospital and Shuang Ho Hospital, which, brings specialized knowledge and access to essential resources for the study. Collaboration with these institutions will support the program's research-intensive structure, providing a robust foundation for both training and therapeutic exploration. Fieldwork Start and End Dates: The fieldwork and internship are scheduled to span 6 months, beginning on 2026/6/1 and concluding on 2027/1/31. This duration is designed to provide interns ample time to complete both coursework and research activities related to therapeutic target discovery. Execution Plan: 1. Training Course Structure: Interns will undergo targeted coursework in oncology, molecular biology, and therapeutic development. Training modules will cover areas such as bioinformatics, molecular assays, cellular function assays, and animal experiments. 2. Internship and Fieldwork Planning: Following the coursework, the two interns will engage in hands-on research, working on experiments central to the discovery of novel therapeutic targets for pediatric brain tumors. Under mentorship, they will learn how to apply laboratory techniques, analyze data, and interpret findings within the context of pediatric oncology. Weekly meetings with mentors and collaborators will facilitate feedback and skill refinement. 3. Subsidy: NT$15,000/Month This structured approach—combining in-depth training, hands-on research, and collaborative mentorship—aims to cultivate skilled researchers who will contribute to future advances in pediatric brain tumor therapy. The program also welcomes applications from candidates interested in the International Master/Ph.D. programs for Translational Science at Taipei Medical University.